[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368427-105":59,"doc-detail-368427-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","global-and-china-burden-of-hormone-related-cancers-and-risk-factors-1990-2021-results-from-the-global-burden-of-disease-study-2021","Global and China burden of hormone-related cancers and risk factors, 1990-2021 - results from the Global Burden of Disease Study 2021","","Updated estimates for hormone-related cancers (HRCs) are essential for effective prevention, management, and treatment aligned with global health goals. This study analyzes breast, thyroid, uterine, ovarian, prostate, and testicular cancers using Global Burden of Disease Study 2021 data (incidence, prevalence, mortality, DALYs, YLDs, and YLLs). Trends and risk factors are assessed with R and Joinpoint, reporting age-standardized rates and percent changes across years, genders, and age groups in China and worldwide. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-and-china-burden-of-hormone-related-cancers-and-risk-factors-1990-2021-results-from-the-global-burden-of-disease-study-2021/368427/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-and-china-burden-of-hormone-related-cancers-and-risk-factors-1990-2021-results-from-the-global-burden-of-disease-study-2021/368427.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which hormone-related cancers are included in the study?","Question",{"text":112,"@type":113},"The study focuses on breast, thyroid, uterine, ovarian, prostate, and testicular cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data sources and metrics are used to assess disease burden?",{"text":117,"@type":113},"Incidence, prevalence, mortality, DALYs, YLDs, and YLLs come from the Global Burden of Disease Study 2021. Trends use age-standardized rates and percent-change measures such as APC and AAPC.",{"name":119,"@type":110,"acceptedAnswer":120},"How does China’s disease burden compare with global levels in 2021?",{"text":121,"@type":113},"In 2021, China reports substantial incidence and death counts for the six HRCs, and age-standardized incidence and death rates differ from global estimates by sex.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368427,1790829265,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Hu etal. BMC Public Health (2025) 25:1566 [https://doi.org/10.1186/s12889-025-22768-3](https://doi.org/10.1186/s12889-025-22768-3)  \nBMC Public Health  \n RESEARCH Open Access  \nGlobal and China burden  \nof hormone-related cancers and risk factors, 1990–2021: results from the Global Burden of Disease Study 2021  \nXiaoyu Hu1,5, Jingjing Lv2,3, Chang Qin1,4, Xiaoxuan Liu 1,5, Jianbiao Zhu1,4 and Yongchun Cui1,5*  \nAbstract  \nBackground Updated data on hormone-related cancers (HRCs) are crucial for their prevention, management, and treatment, aligning with the UN’s Sustainable Development Goals. This study focuses on HRCs: breast, thyroid, uterine, ovarian, prostate, and testicular cancers. Despite their significance, comparative studies on these cancers are limited.  \nMethods Data for incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) related to HRCs were obtained from the Global Burden of Disease Study 2021. Statistical analyses were performed using R and Joinpoint Software. Age-standardized rates (ASR), percentage changes (1990–2021), annual percent change (APC) and average annual percent change (AAPC) are used to examine trendsand risk factors associated with HRCs across various years, genders, and age groups, both in China and globally. Findings In 2021, China reported 659450 incidence cases of six HRCs, including 527009 cases (95% UI: 398030, 684814) in females and 132442 cases (89701, 181113) in males, reflecting a 29. 97% increase since 1990. Deaths attributed to HRCs totaled 176526, with 130281 cases (99207, 166654) among females and 46245 cases (33049, 62510) among males, marking an 11. 07% increase during the same period. The age-standardized incidence rates (ASIR) for HRCs in China were 10.70 (38 . 19, 65 . 86) per 100,000 for females and 13. 87(9 . 50, 18. 71) for males, in contrast to global rates of 17. 07(62 . 11, 72 . 57) for females and 39. 21(35 . 75, 41 . 69) for males. Age-standardized death rates (ASDR) were 3 . 54(9 . 22, 15. 50) for females and 5 . 86(4 . 16, 7 . 83) for males, compared to higher global ASDRs of 6 . 17(19 .49, 22 . 98) and 13. 73(12 . 06, 14. 78),respectively.  \nFrom 1990 to 2021, China and the global population saw significant increases in ASIR for most cancers, except global ovarian cancer (AAPC = -0 . 229) . Female HRCs mortality, YLLs, and DALYs declined significantly, particularly for uterine cancer. Conversely, Chinese males experienced increased mortality, YLLs, and DALYs for breast and thyroid cancers. Testicular cancer prevalence increased among Chinese males (AAPC = 7 . 329) . Specifically, female breast cancer mortality in China decreased from 2011 to 2014 (APC = -2 . 82) . Uterine cancer mortality dropped sharply from 2011 to 2015 (APC = -7 . 91) . Thyroid cancer mortality declined from 2000 to 2007 (APC = -3 . 54), while ovarian cancer mortality decreased from 2000 to 2004 (APC = -3 . 33) . Male breast cancer incidence peaked around 2010, and testicular cancer incidence rose significantly from 2011 to 2015 (APC = 7 . 77) . All above changes were statistically significant (P \u003C 0. 05) .  \n*Correspondence: Yongchun Cui [yccui@sdfmu.edu.cn](yccui@sdfmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indic","cbCaidoooXivEl9J","https://ap.wps.com/l/cbCaidoooXivEl9J","pdf",1427757,17,"English","# Abstract\n## Background\n## Methods\n## Findings\n## Age distribution characteristics\n## Risk factors","[{\"question\":\"Which hormone-related cancers are included in the study?\",\"answer\":\"The study focuses on breast, thyroid, uterine, ovarian, prostate, and testicular cancers.\"},{\"question\":\"What data sources and metrics are used to assess disease burden?\",\"answer\":\"Incidence, prevalence, mortality, DALYs, YLDs, and YLLs come from the Global Burden of Disease Study 2021. Trends use age-standardized rates and percent-change measures such as APC and AAPC.\"},{\"question\":\"How does China’s disease burden compare with global levels in 2021?\",\"answer\":\"In 2021, China reports substantial incidence and death counts for the six HRCs, and age-standardized incidence and death rates differ from global estimates by sex.\"}]","Global and China burden of hormone-related cancers and risk factors, 1990-2021 - results from the Global Burden of Disease Study 2021 | PDF",1790176906,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9379449271112da607654521756f764.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2dd408b80d2fa6984fafcd62fcbb5cf9.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d3cac4d13c336195d438a8618fc9598a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79450a769e058123953baa8206e3cb41.webp",980,1301]